Cervical Cancer Research
ACS’s Updated Cervical Cancer Screening Guidelines ExplainedPosted:
Updated cervical cancer screening guidelines from the American Cancer Society recommend HPV testing as the preferred approach. NCI’s Dr. Nicolas Wentzensen explains the changes and how they compare with other cervical cancer screening recommendations.
AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI studyPosted:
In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.
Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing TypesPosted:
More than a decade after vaccination, women who had received a single dose of the HPV vaccine continued to be protected against infection with the two cancer-causing HPV types targeted by the vaccine, an NCI-funded clinical trial shows.
Women Experience More Side Effects from Pelvic Radiation than RealizedPosted:
Women with cervical or uterine cancer who received radiation to the pelvic region reported side effects much more often using an online reporting system called PRO-CTCAE than they did during conversations with their clinicians, a new study shows.
AI approach outperformed human experts in identifying cervical precancerPosted:
A research team from NIH and Global Good has developed a computer algorithm that can analyze digital images of the cervix and identify precancerous changes that require medical attention. The AI approach could be valuable in low-resource settings.
For HPV-Positive Women, Test Can Guide Cervical Cancer Screening Follow-UpPosted:
A new test can help to improve the clinical management of women who screen positive for HPV infection during routine cervical cancer screening, an NCI-led study has shown.
New Immunotherapy Option Approved for Cervical Cancer, Rare LymphomaPosted:
FDA has approved pembrolizumab (Keytruda) for some women with advanced cervical cancer and some patients with primary mediastinal large B-cell lymphoma (PMBCL), a rare type of non-Hodgkin lymphoma.
Study Identifies Crucial Characteristic of High-Risk HPVPosted:
By comparing the genomes of women infected with a high-risk type of human papillomavirus (HPV), researchers have found that a precise DNA sequence of a viral gene is associated with cervical cancer.
TCGA study identifies genomic features of cervical cancerPosted:
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in subclassification of the disease and may help target therapies that are most appropriate for each patient.
Gardasil 9 Vaccine Protects against Additional HPV TypesPosted:
In a large randomized clinical trial, a new human papillomavirus (HPV) vaccine effectively prevented infection and disease caused by nine HPV types, including seven types that cause cervical and other cancers—five of which were not covered by the previously available HPV vaccines—and two types that cause genital warts.